R&G PharmaStudies Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 2,645

Employees

  • Stock Symbol
  • 301333

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $7.95
  • (As of Friday Closing)

R&G PharmaStudies General Information

Description

R&G PharmaStudies Co Ltd is a clinical trial outsourcing service provider. It offers full-chain clinical research outsourcing services, serving global pharmaceutical and medical device companies and scientific research institutions.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 11th Floor, North Tower, Block B Huatong Building
  • No. 19, Chegongzhuang West Road Haidian District
  • Beijing, 100048
  • China
+86 010
Primary Industry
Other Pharmaceuticals and Biotechnology
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • 11th Floor, North Tower, Block B Huatong Building
  • No. 19, Chegongzhuang West Road Haidian District
  • Beijing, 100048
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

R&G PharmaStudies Stock Performance

As of 13-Nov-2026, R&G PharmaStudies’s stock price is $7.95. Its current market cap is $768M with 96.6M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.95 $8.28 $6.47 - $13.15 $768M 96.6M 2.78M $0.18

R&G PharmaStudies Financials Summary

As of 30-Sep-2026, R&G PharmaStudies has a trailing 12-month revenue of $139M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 718,686 583,456 437,817 642,037
Revenue 138,904 118,338 103,687 101,963
EBITDA 17,350 25,380 26,205 29,189
Net Income 16,904 19,037 19,542 22,973
Total Assets 360,922 342,966 320,026 292,557
Total Debt 7,471 6,364 13,495 1,251
Public Fundamental Data provided by Morningstar, Inc. disclaimer

R&G PharmaStudies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore R&G PharmaStudies‘s full profile, request access.

Request a free trial

R&G PharmaStudies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

R&G PharmaStudies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore R&G PharmaStudies‘s full profile, request access.

Request a free trial

R&G PharmaStudies Investments (1)

R&G PharmaStudies’s most recent deal was a Early Stage VC with Genfleet for . The deal was made on 30-Mar-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Genfleet 30-Mar-2020 Early Stage VC Drug Discovery
To view R&G PharmaStudies’s complete investments history, request access »

R&G PharmaStudies ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view R&G PharmaStudies’s complete esg history, request access »

R&G PharmaStudies Exits (1)

R&G PharmaStudies’s most recent exit was on 30-Mar-2020 from Genfleet. The exit was categorized as with 11 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Genfleet 30-Mar-2020 Completed
  • 11 buyers
To view R&G PharmaStudies’s complete exits history, request access »

R&G PharmaStudies FAQs

  • When was R&G PharmaStudies founded?

    R&G PharmaStudies was founded in 2008.

  • Where is R&G PharmaStudies headquartered?

    R&G PharmaStudies is headquartered in Beijing, China.

  • What is the size of R&G PharmaStudies?

    R&G PharmaStudies has 2,645 total employees.

  • What industry is R&G PharmaStudies in?

    R&G PharmaStudies’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is R&G PharmaStudies a private or public company?

    R&G PharmaStudies is a Public company.

  • What is R&G PharmaStudies’s stock symbol?

    The ticker symbol for R&G PharmaStudies is 301333.

  • What is the current stock price of R&G PharmaStudies?

    As of 13-Nov-2026 the stock price of R&G PharmaStudies is $7.95.

  • What is the current market cap of R&G PharmaStudies?

    The current market capitalization of R&G PharmaStudies is $768M.

  • What is R&G PharmaStudies’s current revenue?

    The trailing twelve month revenue for R&G PharmaStudies is $139M.

  • What is R&G PharmaStudies’s annual earnings per share (EPS)?

    R&G PharmaStudies’s EPS for 12 months was $0.18.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process